Hawighorst H, Schoenberg S O, Knapstein P G, Knopp M V, Schaeffer U, Essig M, van Kaick G
Department of Radiological Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany.
J Comput Assist Tomogr. 1998 Jan-Feb;22(1):75-81. doi: 10.1097/00004728-199801000-00013.
Our goal was to stage invasive cervical carcinoma (pT1b-pT4a) and pelvic lymph nodes by high resolution MRI with a circularly polarized (cp) phased-array coil in correlation with the whole-mount specimen and the histopathological findings.
Thirty-three patients (20-68 years old; mean age 55 years) with biopsy-proven primary cancer of the cervix were prospectively examined on a 1.5 T scanner by using a cp body phased-array coil. The MR protocol consisted of high resolution T2-weighted turbo-SE (TSE) and pre- and postcontrast T1-weighted SE (SE) sequences. Slice thickness was 5-7 mm with a pixel size of 0.3-0.4 mm2. All MRI findings were matched to the whole-mount specimens and the histopathological findings.
Pathological stages evaluated were pT1b (n = 5), pT2b (n = 16), and pT4a (n = 12). The overall accuracy rates for tumor staging were 79% for high resolution T2-weighted TSE and 76% for postcontrast T1-weighted SE images. The accuracy for high resolution T2-weighted TSE images in determining parametrial infiltration, pelvic side wall, and bladder and rectal wall infiltration was 84, 87, and 87%, respectively. In prospective analysis of the 1.0 cm criterion for diagnosis of a positive pelvic lymph node, MRI had a 72% accuracy, a 68% sensitivity, and a 78% specificity.
High resolution MRI with a cp body phased-array coil provides excellent and robust high resolution images in patients with invasive cervical carcinoma. However, accuracy, specificity, and sensitivity for staging invasive cervical carcinoma and pelvic lymph nodes with correlation to whole-mount specimens and histopathological findings did not improve compared with the results in the literature using a body coil with thicker slices and a lower spatial resolution.
我们的目标是通过使用圆极化(cp)相控阵线圈的高分辨率MRI对浸润性宫颈癌(pT1b - pT4a)和盆腔淋巴结进行分期,并与整装标本及组织病理学结果进行对照。
对33例经活检证实为原发性宫颈癌的患者(年龄20 - 68岁;平均年龄55岁),使用cp体部相控阵线圈在1.5T扫描仪上进行前瞻性检查。MR检查方案包括高分辨率T2加权快速自旋回波(TSE)序列以及对比剂注射前后的T1加权自旋回波(SE)序列。层厚为5 - 7mm,像素大小为0.3 - 0.4mm²。所有MRI结果均与整装标本及组织病理学结果进行比对。
评估的病理分期为pT1b(n = 5)、pT2b(n = 16)和pT4a(n = 12)。高分辨率T2加权TSE序列对肿瘤分期的总体准确率为79%,对比剂注射后T1加权SE图像的总体准确率为76%。高分辨率T2加权TSE图像在判断宫旁浸润、盆腔侧壁以及膀胱和直肠壁浸润方面的准确率分别为84%、87%和87%。在对盆腔淋巴结阳性诊断的1.0cm标准进行前瞻性分析时,MRI的准确率为72%,敏感性为68%,特异性为78%。
使用cp体部相控阵线圈的高分辨率MRI可为浸润性宫颈癌患者提供出色且稳定的高分辨率图像。然而,与使用层厚更厚、空间分辨率更低的体线圈的文献结果相比,在与整装标本及组织病理学结果相关的浸润性宫颈癌和盆腔淋巴结分期方面,其准确率、特异性和敏感性并未提高。